Skip to main content
Sign In
 

Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS AQ-Cardiology

Associate Professor, Department of Clinical Pharmacy


Clinical Specialist – Cardiology/Anticoagulation
University of Colorado Hospital
Co-Chair, Anticoagulation Program UC Health

Mailing address:

University of Colorado School of Pharmacy
Mail Stop C238
12850 E. Montview Blvd. V20-1217
Aurora, CO 80045

Office Location:

Pharmacy and Pharmaceutical Sciences Building (V20)
First Floor
Room 1217

Contact information:

Telephone: 303-724-2623
Email: Toby.Trujillo@CUAnschutz.edu​​

Training and Education

  • Bachelor of Science Biochemistry, University of California-Davis (1990)
  • Doctor of Pharmacy, University of California-San Francisco (1994)
  • Pharmacy Practice Residency (PGY1), University of California-San Francisco (1994 – 1995)
  • Fellowship in Cardiovascular Pharmacotherapy. University of Arizona College of Pharmacy/University Medical Center (1995 – 1997)

Certifications and Fellowships

  • Board Certified Pharmacotherapy Specialist (BCPS)with Added Qualifications in Cardiology
  • Fellow of the America Heart Association (2013)
  • Fellow of the American College of Clinical Pharmacy (2013)

Previous Academic Appointments

  • Clinical Associate Professor in Pharmacy Practice. Northeastern University School of Pharmacy, Boston, Massachusetts. (2005 – 2008).
  • Clinical Assistant Professor in Pharmacy Practice. Northeastern University School of Pharmacy, Boston, Massachusetts. (2004 – 2005)
  • Adjunct Assistant Professor of Clinical Pharmacy. Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts (2002 – 2004)
  • Assistant Professor of Clinical Pharmacy. Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts. (1997 – 2001)

Teaching Activities

Dr. Trujillo teaches in the Entry Level and the Distance Degree PharmD programs. His primary areas are related to acute cardiovascular disorders (e.g., acute coronary syndromes, arrhythmias) as well as hemostasis and the treatment of thromboembolic disorders (e.g. prevention and treatment of VTE, optimal use of antithrombotic agents). He is a course director of Patient-Centered Communications 2 (PHRD 5965), Pharmacotherapy 4 (PHRD 6985), and the Advanced Cardiovascular Pharmacotherapy (PHRD 7385) courses. Dr. Trujillo also precepts 4th year APPE students (Inpatient anticoagulation/cardiology), PGY1 residents (academia, anticoagulation), and PGY2 residents (research project). Dr. Trujillo also is co-director of the Colorado Pharmacy Residency Teaching Certificate Program, for more information see below.

Clinical Activities

Dr. Trujillo serves as a clinical pharmacy specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital. In his current role, Dr. Trujillo is involved in the stewardship of antithrombotic medications across the UC Health System, which includes serving as co-chair of the anticoagulation subcommittee of the P&T committee, as well as coordinating and staffing the Inpatient-Anticoagulation Thrombosis Management Service.

Scholarly Activities

Dr. Trujillo has served as a speaker on numerous occasions on a national and international level, and has published over 70 original research articles, review articles, and book chapters dealing with the area of cardiovascular pharmacotherapy. His research interests primarily focus on the appropriate use of antithrombotic medications, both at the patient and health-system level.

Recent Publications

  • Beyer J, Lind SE, Fisher S, Trujillo TC, Wempe MF, Kiser TK. Evaluation of Intravenous Direct Thrombin Inhibitor Monitoring Tests, Correlation with Plasma Concentrations and Clinical Outcomes in Hospitalized Patients. Clinical and Applied Thrombosis/Hemostasis. In Press, 2019.
  • Dobesh PP, Shah B, Trujillo TC, Glaubius T. Antidotes for Reversal of Direct Oral Anticoagulants. Pharmacology and Therapeutics. In press, 2019.
  • Trujillo TC, Finks S, Dobesh P, Crossley G. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Non-Valvular Atrial Fibrillation. Online publication. Pharmacotherapy 2019 10.1002/phar.2205.
  • Finks SW, Dobesh PP, Trujillo TC, Crossley G. Peri-procedural management of direct oral anticoagulants surrounding cardioversion and invasive electrophysiological procedures. Cardiol Rev. 2018;26:245-54.
  • Trujillo JM, McNair CD, Linnebur SA, Valdez C, Trujillo TC. The Impact of a Stand Alone Communications Course Series Integrated with Pharmacotherapy Courses and IPPEs. Am J Pharm Education. 2016: 80(10):article 174.
  • Smythe M, Fanikos J, Trujillo TC. Urgent Bleed Management With Direct Oral Anticoagulants. Am J Health-Syst Pharm. 2016; 73(suppl 2):S27-48
  • Finks SW, Trujillo TC, Dobesh PP. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. Annals of Pharmacotherapy 2016, Vol. 50(6) 486–501
  • Beyer J, Trujillo TC, Babilonia K, Fisher S, Ko A, Lind S, Kiser T. Evaluation of a Global Anti Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors. Clinical Applied Thrombosis and Hemostasis 2016. http://cat.sagepub.com/content/early/2016/02/02/1076029616629759?papetoc
  • Knapp K, Meszaros K, Goldsmith PC, McCarter GC, Hester KE, McBane S, Bottorff M, Carnes T, Dell K, Gonyeau MJ, Greco AJ, McConnell KJ, Skaar D, Splinter MY, Trujillo TC. Alternative Viewpoint: Preparation for Residency. Pharmacotherapy 2014;34(8):e157–e158) doi: 10.1002/phar.1475.
  • Anderson M, Hassell K, Trujillo TC, Wolfe B. Perioperative Management of the Target Specific Oral Anticoagulants. Cleveland Clinic Journal of Medicine. VOLUME 81 • NUMBER 10 OCTOBER 2014.
  • Trujillo TC, Dobesh P. Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmcodynamic rationale for Dosing Regimens in Different Indications. Drugs (2014) 74:1587–1603
  • Babilonia K, Golightly L, Hassell K, Kaiser JN, Kiser TH, Klem P, Trujillo TC. Antithrombotic Therapy in Thrombocytopenic Cancer Patients: Efficacy and Safety of Reduced-Dose Low Molecular Weight Heparin during Hospitalization. Clinical and Applied Thrombosis/Hemostasis 2014, Vol. 20(8) 799-806.
  • Babilonia K, Trujillo TC. The Role of Prothrombin Complex Concentrates in Reversal of target Specific Anticoagulants. Thrombosis Journal. 2014, 12:8 DOI: 10.1186/1477-9560-12-8.
  • Miller MP, Trujillo TC, Nordenholz KE. ED Management of Bleeding in the Setting of Target Specific Oral Anticoagulants. American Journal of Emergency Medicine 32 (2014) 375–382.
  • Misky G, Carlson T, Thompson E, Trujillo TC, Nordenholz K. Implementation of an Acute Venous Thromboembolism Clinical Pathway Reduces Health Care Utilization and Mitigates Health Disparities. Journal of Hospital Medicine. 2014 http://onlinelibrary.wiley.com/doi/10.1002/jhm.2186/pdf
  • Hester K, McBane S, Bottorff M, Carnes, T, Dell K, Gonyeau M, Greco A, McConnell KA, Sanoski C, Skaar DJ, Splinter MY, Trujillo TC. ACCP Position Statement – Educational Outcomes Necessary to Enter Pharmacy Residency Training. Pharmacotherapy 2014;34(4):e22–e25) doi: 10.1002/phar.1411.
  • Lind SE, Boyle ME, Fisher S, Ishimoto J, Trujillo TC, Kiser T. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples. Am J Clin Pathol May 2014;141:665-674.
  • Dobesh PP, Trujillo TC, Finks S. Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism. Pharmacotherapy 2013;33(6):650–664.
  • Burnett A, Trujillo TC. The Future of Inpatient Anticoagulation Management. J Thromb Thrombolysis (2013) 35:375–386.

Professional Memberships and Service:

  • Member, Board of Directors, Pharmacotherapy Publications, Inc. American College of Clinical Pharmacy. American College of Clinical Pharmacy (2018-2019)
  • Member, CVT Executive Council. Colorado Chapter of the American College of Cardiology (2017 – 2020)
  • CVT Member of the Cardiovascular Team Section Leadership Council. American College of Cardiology, National. (2017 – 2020)
  • Member, Board of Regents. American College of Clinical Pharmacy (2016 – 2019)
  • Member – Special Advisory Group on Clinical Leadership. Section of Clinical Specialists and Scientists, ASHP.
  • American Association of Colleges of Pharmacy
  • American Society of Health-system Pharmacists
  • American Pharmacists Association
  • American Heart Association
  • American College of Cardiology
  • International Society of Thrombosis and Hemostasis
  • Society of Critical Care Medicine
  • Colorado Pharmacists Society

Colorado Pharmacy Residency Teaching Certificate (CPRTC) Program

Co-director:
  • Academic year 2010-2011: 25 residents completed program
  • Academic year 2011-2012: 38 residents/fellows completed program
  • Academic year 2012-2013: 42 residents/fellows/preceptors completed program
  • Academic year 2013-2014: 44 residents/fellows/preceptors completed program
  • Academic year 2014-2015: 42 residents/fellows/preceptors completed program
  • Academic year 2015-2016: 55 residents/fellows/preceptors completed program
  • Academic year 2016-2017: 55 residents/fellows/preceptors completed program
  • Academic year 2017-2018: 58 residents/fellows/preceptors completed program
  • Academic year 2018-2019: 59 residents/fellows/preceptors completed program
  • Academic year 2019-2020: 58 enrolled

Colorado Pharmacy Residency Teaching Certificate (CPRTC) Program